IFNB1 and cutaneous mucinosis: Drug-related mucinosis has been linked to interferon alfa-1, interferon beta-1, interleukin 12/23 inhibitors (ustekinumab), tumor necrosis factor-alfa inhibitors and interleukin 6 inhibitors (tocilizumab).